ECSP12011786A - Material inviable derivado de probióticos para la prevención y el tratamiento de alergias - Google Patents
Material inviable derivado de probióticos para la prevención y el tratamiento de alergiasInfo
- Publication number
- ECSP12011786A ECSP12011786A ECSP12011786A ECSP12011786A EC SP12011786 A ECSP12011786 A EC SP12011786A EC SP12011786 A ECSP12011786 A EC SP12011786A EC SP12011786 A ECSP12011786 A EC SP12011786A
- Authority
- EC
- Ecuador
- Prior art keywords
- composition
- allergies
- inviable
- probiotics
- prevention
- Prior art date
Links
- 230000007815 allergy Effects 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 239000000463 material Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 230000003266 anti-allergic effect Effects 0.000 abstract 2
- 239000012228 culture supernatant Substances 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 238000010923 batch production Methods 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Pediatric Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09170124A EP2295535A1 (en) | 2009-09-11 | 2009-09-11 | Probiotic material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP12011786A true ECSP12011786A (es) | 2012-07-31 |
Family
ID=41561153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP12011786 ECSP12011786A (es) | 2009-09-11 | 2012-04-05 | Material inviable derivado de probióticos para la prevención y el tratamiento de alergias |
Country Status (20)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130095189A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Composition and method of phytonutrients for metabolic programming effects |
| US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) * | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US8889633B2 (en) * | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US20150305384A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| MX2016015153A (es) * | 2014-05-20 | 2017-03-07 | Biogaia Ab | Complementacion de microbioma neonatal. |
| US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
| US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
| JP7057059B2 (ja) | 2016-08-22 | 2022-04-19 | 株式会社明治 | ラクトバチルス・プランタラムの培養物の製造方法 |
| US20180064739A1 (en) | 2016-09-06 | 2018-03-08 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| US20180103675A1 (en) | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
| US10980269B2 (en) | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
| US20180161292A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180160714A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180168215A1 (en) | 2016-12-21 | 2018-06-21 | Mead Johnson Nutrition Company | Nutritional compositions containing inositol and uses thereof |
| US20180332881A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Preterm infant formula containing butyrate and uses thereof |
| US20180333426A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| AU2018362747B2 (en) * | 2017-11-07 | 2025-08-14 | Hubit Genomix, Inc. | Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression |
| US20190208807A1 (en) | 2018-01-05 | 2019-07-11 | Mead Johnson Nutrition Company | Nutritional compositions containing milk-derived peptides and uses thereof |
| EP3524051A1 (en) * | 2018-02-12 | 2019-08-14 | DuPont Nutrition Biosciences ApS | Matricial microencapsulation compositions |
| CN119040223B (zh) * | 2024-11-01 | 2025-02-28 | 微康益生菌(苏州)股份有限公司 | 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| ZA92452B (en) | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| US6506389B2 (en) | 1995-10-20 | 2003-01-14 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) | Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| CA2206674A1 (en) * | 1996-05-30 | 1997-11-30 | Gregor Reid | Lactobacillus therapies |
| EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
| WO2000071138A2 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
| NZ536894A (en) | 2000-08-08 | 2006-04-28 | Vialactia Bioscience Nz Ltd | Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| EP1458247B1 (en) * | 2001-12-20 | 2014-01-22 | Biolactis Inc. | Malleable protein matrix and uses thereof |
| EP1572145A1 (en) * | 2002-12-13 | 2005-09-14 | L'oreal | Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration |
| US20040208863A1 (en) | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| ATE433674T1 (de) * | 2003-06-23 | 2009-07-15 | Nestec Sa | Säuglingsnährpräparat oder folgemilch |
| JP2008501316A (ja) | 2004-04-20 | 2008-01-24 | ザ ユニヴァーシティー オヴ シカゴ | ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用 |
| US20100233312A9 (en) * | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
| US20060233772A1 (en) * | 2005-04-15 | 2006-10-19 | Udo Herz | Method for preventing or treating the development of respiratory allergies |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| US9133249B2 (en) * | 2006-10-24 | 2015-09-15 | Vanderbilt University | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| JP2010523695A (ja) * | 2007-04-11 | 2010-07-15 | アルコン リサーチ， リミテッド | アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用 |
| WO2009137159A2 (en) * | 2008-04-17 | 2009-11-12 | Trustees Of Dartmouth College | Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same |
-
2009
- 2009-09-11 EP EP09170124A patent/EP2295535A1/en not_active Ceased
-
2010
- 2010-09-10 MX MX2012002716A patent/MX345077B/es active IP Right Grant
- 2010-09-10 PL PL10757324T patent/PL2475764T3/pl unknown
- 2010-09-10 ES ES10757324.8T patent/ES2614929T3/es active Active
- 2010-09-10 JP JP2012528768A patent/JP2013504321A/ja active Pending
- 2010-09-10 WO PCT/NL2010/050576 patent/WO2011031149A1/en not_active Ceased
- 2010-09-10 BR BR112012005533A patent/BR112012005533A2/pt not_active Application Discontinuation
- 2010-09-10 KR KR1020127003851A patent/KR20120061836A/ko not_active Withdrawn
- 2010-09-10 MY MYPI2012000513A patent/MY160646A/en unknown
- 2010-09-10 US US12/879,136 patent/US20110217402A1/en not_active Abandoned
- 2010-09-10 AU AU2010293145A patent/AU2010293145B2/en not_active Ceased
- 2010-09-10 CN CN201080040659XA patent/CN102575224A/zh active Pending
- 2010-09-10 NZ NZ597818A patent/NZ597818A/en not_active IP Right Cessation
- 2010-09-10 PE PE2012000122A patent/PE20121557A1/es not_active Application Discontinuation
- 2010-09-10 EP EP10757324.8A patent/EP2475764B1/en not_active Not-in-force
- 2010-09-10 CA CA2772593A patent/CA2772593C/en not_active Expired - Fee Related
- 2010-09-10 IN IN951DEN2012 patent/IN2012DN00951A/en unknown
- 2010-09-10 RU RU2012114190/10A patent/RU2012114190A/ru not_active Application Discontinuation
- 2010-09-10 TW TW099130665A patent/TWI595090B/zh not_active IP Right Cessation
- 2010-09-10 SG SG2012007449A patent/SG178230A1/en unknown
-
2012
- 2012-04-05 EC ECSP12011786 patent/ECSP12011786A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG178230A1 (en) | 2012-03-29 |
| EP2475764B1 (en) | 2016-12-14 |
| EP2475764A1 (en) | 2012-07-18 |
| ES2614929T3 (es) | 2017-06-02 |
| TWI595090B (zh) | 2017-08-11 |
| JP2013504321A (ja) | 2013-02-07 |
| IN2012DN00951A (cg-RX-API-DMAC7.html) | 2015-04-10 |
| US20110217402A1 (en) | 2011-09-08 |
| EP2295535A1 (en) | 2011-03-16 |
| TW201124529A (en) | 2011-07-16 |
| RU2012114190A (ru) | 2013-10-20 |
| KR20120061836A (ko) | 2012-06-13 |
| PE20121557A1 (es) | 2012-11-21 |
| BR112012005533A2 (pt) | 2016-04-26 |
| CA2772593C (en) | 2018-11-27 |
| CA2772593A1 (en) | 2011-03-17 |
| MX2012002716A (es) | 2012-04-19 |
| MX345077B (es) | 2017-01-16 |
| PL2475764T3 (pl) | 2017-06-30 |
| AU2010293145A1 (en) | 2012-03-08 |
| AU2010293145B2 (en) | 2016-04-14 |
| MY160646A (en) | 2017-03-15 |
| CN102575224A (zh) | 2012-07-11 |
| WO2011031149A1 (en) | 2011-03-17 |
| NZ597818A (en) | 2014-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP12011786A (es) | Material inviable derivado de probióticos para la prevención y el tratamiento de alergias | |
| AR090473A1 (es) | Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion | |
| Cheung et al. | Molecular properties and antioxidant activities of polysaccharide–protein complexes from selected mushrooms by ultrasound-assisted extraction | |
| Marudhupandi et al. | In vitro anticancer activity of fucoidan from Turbinaria conoides against A549 cell lines | |
| SA518400424B1 (ar) | جزيئات الجسم المضاد لعلاج السرطان | |
| SG10201809146QA (en) | Recombinant host cell engineered to overexpress helper proteins | |
| SG10201809152QA (en) | Recombinant host cell for expressing proteins of interest | |
| MX363819B (es) | Uniones a cdim y sus usos. | |
| MX2010006610A (es) | Conjugados de factor de crecimiento de nervios y usos de los mismos. | |
| WO2015149944A3 (en) | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant | |
| MX336839B (es) | Formacion de complejos de acidos nucleicos con componentes cationicos entrelazados por disulfuro para transfeccion e inmunoestimulacion. | |
| BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
| MX355834B (es) | Metodo para preparar composiciones botanicas bioactivas y composiciones preparadas a partir de dicho metodo. | |
| MY175804A (en) | Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments | |
| AR106578A1 (es) | Composiciones nutricionales para la promoción de la función de barrera intestinal y alivio del dolor visceral | |
| Hassan et al. | The immune-modulator activity of Pseudomonas aeruginosa extracted protein: Azurin Charming Protein | |
| Omidi et al. | Effects of postbiotics from food probiotic and protective cultures on proliferation and apoptosis in HCT-116 colorectal cancer cells | |
| PH12023550246A1 (en) | Modified chikungunya viruses and sindbis viruses and uses thereof | |
| EA201390059A1 (ru) | Способ производства продуктов, способных настаиваться для получения напитков | |
| TH138555A (th) | สารโปรไบโอติก | |
| 李凤磊 et al. | Microbiota improve immune defense against hepadnavirus infection through promoting hepatic γδT-17 cells | |
| Chu et al. | Stem cell transplantation for nonunion: an evaluation of its effect | |
| Donzelli et al. | Human Mesenchymal Stem Cells and Endothelial Progenitor Cells exert a neuroprotective effect on rat cortical neurons injured by oxygen and glucose deprivation | |
| Zou et al. | Preparation of Medical Low-temperature Wood-plastic Polycaprolactone Composites and their Properties | |
| Zsiros et al. | Chemokine receptors enhance T-cell vaccine cell homing to ovarian cancer |